Screener
Protagonist Therapeutics PTGX Business Segments — Segment Reporting Other Item Amount
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Protagonist Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:SegmentReportingOtherItemAmount.
The source filing: Protagonist Therapeutics’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:17 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-091123
| Line item | Three Months Ended / June 30, 2026 | Three Months Ended / June 30, 2025 | Six Months Ended / June 30, 2026 | Six Months Ended / June 30, 2025 |
|---|---|---|---|---|
| Employee wages and benefits - discovery (2) | (2,668) | (2,188) | (5,816) | (4,515) |
| Employee wages and benefits - development (2) | (4,949) | (4,658) | (10,901) | (10,142) |
| Employee wages and benefits - general and administrative | (4,357) | (3,483) | (9,080) | (7,315) |
| Stock-based compensation expense | (14,037) | (10,912) | (28,556) | (24,714) |
| Other segment items (3) | (81) | 36 | (28) | 118 |
| Interest income | 6,429 | 7,406 | 12,305 | 14,979 |
| Income tax expense | (2,265) | (172) | (763) | (172) |
| Consolidated net income (loss) | $162,849 | $(34,771) | $166,632 | $(46,426) |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Protagonist Therapeutics's business segments — segment reporting other item amount?
- Protagonist Therapeutics (PTGX) reported business segments — segment reporting other item amount of $81K in Q2 2026.
- How has Protagonist Therapeutics's business segments — segment reporting other item amount changed year-over-year?
- Protagonist Therapeutics's business segments — segment reporting other item amount increased by 325.0% year-over-year, from -$36K to $81K.
- What is the long-term trend for Protagonist Therapeutics's business segments — segment reporting other item amount?
- Over 2 years (2022 to 2024), Protagonist Therapeutics's business segments — segment reporting other item amount has grown at a 76.8% compound annual growth rate (CAGR), from $80K to -$250K.
- What does business segments — segment reporting other item amount mean?
- This captures miscellaneous income or expense items that do not fit into the primary operating categories of the business segment. It may include non-recurring gains, losses, or adjustments that impact the segment's overall financial performance. Tracking this helps isolate core operational results from irregular or incidental financial events.
Ask your AI about Protagonist Therapeutics's business segments — segment reporting other item amount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude